SPC3649

DRUG2 trials

Sponsors

Santaris Pharma A/S

Conditions

Hepatitis C

Phase 1

Safety Study of SPC3649 in Healthy Men

CompletedNCT00688012

Santaris Pharma A/SHepatitis C

Start: 2008-05-31End: 2009-05-31Target: 64Updated: 2009-09-18

SPC3649 Multiple Dose Study in Healthy Volunteers

CompletedNCT00979927

Santaris Pharma A/SHepatitis C

Start: 2009-09-30End: 2010-09-30Target: 30Updated: 2011-10-05